Trikafta (elexacaftor/tezacaftor/ivacaftor) - Vertex
Feasibility and Impact of a Coached Home-Based Exercise Program on Cardiorespiratory Fitness in Adults With Cystic Fibrosis on Highly Effective Modulator Therapy. (PubMed, CHEST Pulm) - Sep 13, 2026 - P2 | "This randomized controlled pilot study enrolled PwCF on stable elexacaftor/tezacaftor/ivacaftor...These findings support the feasibility of a home-based exercise coaching program. ClinicalTrials.gov; No.: NCT05239611; URL: www.clinicaltrials.gov." 
Journal • Cystic Fibrosis • Genetic Disorders • Immunology • Pulmonary Disease • Respiratory Diseases
http://www.ncbi.nlm.nih.gov/pubmed/42729704
 
Allison Bustos; Ashley Barry; Dave Burnett; Jianghua He; Joel Mermis; Peter Niedbalski
 
Sep 13, 2026
 
Prev Next